Frontal parenchymal atrophy measures in multiple sclerosis

Abstract

The aim of this study was to establish whether, in a cross-sectional study, the normalized measures of whole and regional brain atrophy correlate better with tests assessing the cognitive function than the absolute brain atrophy measures. The neuropsychological performances and disability have been assessed in 39 patients with relapsing-remitting multiple sclerosis (MS). T1- and T2-lesion load (LL) of total brain and frontal lobes (FLs) were measured using a reproducible semiautomated technique. The whole brain volume and the regional brain parenchymal volume (RBPV) of FLs were obtained using a computerized interactive program, which incorporates semiautomated and automated segmentation processes. Normalized measures of brain atrophy, i.e., brain parenchymal fraction (BPF) and regional brain parenchymal fraction (RBPF) of FLs, were calculated. The scan-rescan, inter- and intrarater coefficient of variation (COV) and intraclass correlation coefficient (ICC) have been estimated. The RBPF of FLs showed an acceptable level of reproducibility which ranged from 1.7% for intrarater variability to 3.2% for scan-rescan variability. The mean ICC was 0.88 (CI 0.82-0.93). The RBPF of FLs demonstrated stronger magnitudes of correlation with neuropsychological functioning, disability and quantitative MRI lesion measures than RBPV. These differences were statistically significant: P=0.001 for Stroop Color Word Interference test, P=0.001 for Paced Auditory Serial Addition Test, P=0.04 for Standard Raven Progressive Matrices, P=0.049 for Expanded Disability Status Scale, P=0.01 for T2-LL of FLs and P< 0.001 for T1-LL of FLs. BPF demonstrated significant correlations with tests assessing cognitive functions, whereas BPAV did not. The correlation analysis results were supported by the results of multiple regression analysis which showed that only the normalized brain atrophy measures were associated with tests exploring the cognitive functions. These data suggest that RBPF is a reproducible and sensitive method for measuring frontal parenchymal atrophy. The normalized measures of whole and regional brain parenchymal atrophy should be preferred to absolute measures in future studies that correlate neuropsychological performances and brain atrophy measures in patients with MS.

Keywords

cognitive function frontal brain atrophy MRI multiple sclerosis normalized measures

Get full access to this article

View all access options for this article.

References

Simon JH , Jacobs LD , Campion MK , Rudick RA , Cookfair DL , Herndon RM et al. A longitudinal study of brain atrophy in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG) . Neurology 1999; 53: 139-148 .

Edwards SG , Gong QY , Liu C , Zvartau ME , Jaspan T , Roberts N et al. Infratentorial atrophy on magnetic resonance imaging and disability in multiple sclerosis . Brain 1999; 122: 291-301 .

Bakshi R , Czarnecki D , Shaikh ZA , Priore RL , Janardhan V , Kaliszky Z et al. Brain MRI lesions and atrophy are related to depression in multiple sclerosis . Neuroreport 2000; 11: 1153-1158 .

Brex PA , Jenkins R , Fox NC , Crum WR , O’Riordan JI , Plant GT et al. Detection of ventricular enlargement in patients at the earliest clinical stage of MS . Neurology 2000; 54: 1689-1691 .

Bermel RA , Bakshi R , Tjoa C , Puli SR , Jacobs L. Bicaudate ratio as a magnetic resonance imaging marker of brain atrophy in multiple sclerosis . Arch Neurol 2002; 59: 275-280 .

Rovaris M , Comi G , Rocca MA , Wolinsky JS , Filippi M. Short-term brain volume change in relapsing-remitting multiple sclerosis: effect of glatiramer acetate and implications . Brain 2001; 124: 1803-1812 .

Losseff NA , Wang L , Lai HM , Yoo DS , Gawne-Cain ML , McDonald WI et al. Progressive cerebral atrophy in multiple sclerosis. A serial MRI study . Brain 1996; 119: 2009-2019 .

Zivadinov R , Bakshi R. Role of MRI in multiple sclerosis II: brain and spinal cord atrophy . Front Biosci 2004; 9: 647-664 .

Rudick RA , Fisher E , Lee JC , Simon J , Jacobs L. Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group . Neurology 1999; 53: 1698-1704 .

10.

Liu C , Edwards S , Gong Q , Roberts N , Blumhardt LD. Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis . J Neurol Neurosurg Psychiatry 1999; 66: 323-330 .

11.

Phillips MD , Grossman RI , Miki Y , Wei L , Kolson DL , van Buchem MA et al. Comparison of T2 lesion volume and magnetization transfer ratio histogram analysis and of atrophy and measures of lesion burden in patients with multiple sclerosis . AJNR Am J Neuroradiol 1998; 19: 1055-1060 .

12.

Zivadinov R , De Masi R , Nasuelli D , Bragadin LM , Ukmar M , Pozzi-Mucelli RS et al. MRI techniques and cognitive impairment in the early phase of relapsing-remitting multiple sclerosis . Neuroradiology 2001; 43: 272-278 .

13.

Whitwell JL , Crum WR , Watt HC , Fox NC. Normalization of cerebral volumes by use of intracranial volume: implications for longitudinal quantitative MR imaging . AJNR Am J Neuroradiol 2001; 22: 1483-1489 .

14.

Chard DT , Griffin CM , Parker GJ , Kapoor R , Thompson AJ , Miller DH. Brain atrophy in clinically early relapsing-remitting multiple sclerosis . Brain 2002; 125: 327-337 .

15.

Bermel RA , Sharma J , Tjoa CW , Puli SR , Bakshi R. A semiautomated measure of whole-brain atrophy in multiple sclerosis . J Neurol Sci 2003; 208: 57-65 .

16.

Zivadinov R , Locatelli L , Stival B , Bratina A , Grop A , Nasuelli D et al. Normalized regional brain atrophy measurements in multiple sclerosis . Neuroradiology 2003; 45: 793-798 .

17.

Rao SM , Leo GJ , Haughton VM , St Aubin-Faubert P , Bernardin L. Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis . Neurology 1989; 39: 161-166 .

18.

Comi G , Filippi M , Martinelli V , Sirabian G , Visciani A , Campi A et al. Brain magnetic resonance imaging correlates of cognitive impairment in multiple sclerosis . J Neurol Sci 1993; 115: S66-S73 .

19.

Rovaris M , Filippi M. MRI correlates of cognitive dysfunction in multiple sclerosis patients . J Neurovirol 2000; 6: S172-S175 .

20.

van Buchem MA , Grossman RI , Armstrong C , Polansky M , Miki Y , Heyning FH et al. Correlation of volumetric magnetization transfer imaging with clinical data in MS . Neurology 1998; 50: 1609-1617 .

21.

Zivadinov R , Sepcic J , Nasuelli D , De Masi R , Bragadin LM , Tommasi MA et al. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis . J Neurol Neurosurg Psychiatry 2001; 70: 773-780 .

22.

Hohol MJ , Guttmann CR , Orav J , Mackin GA , Kikinis R , Khoury SJ et al. Serial neuropsychological assessment and magnetic resonance imaging analysis in multiple sclerosis . Arch Neurol 1997; 54: 1018-1025 .

23.

McDonald WI , Compston A , Edan G , Goodkin D , Hartung HP , Lublin FD et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis . Ann Neurol 2001; 50: 121-127 .

24.

Lublin FD , Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis . Neurology 1996; 46: 907-911 .

25.

Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) . Neurology 1983; 33: 1444-1452 .

26.

Gronwall DM. Paced auditory serial-addition task: a measure of recovery from concussion . Percept Mot Skills 1977; 44: 367-373 .

27.

Stroop JR. Studies of interference in serial verbal reactions . J Exp Psychol 1935; 18: 643-662 .

28.

Raven JC. Guide to the standard progressive matrices. London: H.K. Lewis , 1960.

29.

Miller DH , Barkhof F , Berry I , Kappos L , Scotti G , Thompson AJ. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines . J Neurol Neurosurg Psychiatry 1991; 54: 683-688 .

30.

Grimaud J , Lai M , Thorpe J , Adeleine P , Wang L , Barker GJ et al. Quantification of MRI lesion load in multiple sclerosis: a comparison of three computer-assisted techniques . Magn Reson Imaging 1996; 14: 495-505 .

31.

Zivadinov R , Rudick RA , De Masi R, Nasuelli D , Ukmar M , Pozzi-Mucelli RS et al. Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS . Neurology 2001; 57: 1239-1247 .

32.

Kikinis R , Portas CM , Donnino RM , Jolesz FA , Shenton ME , Iosifescu DV et al. Digital brain atlas for surgical planning, model-driven segmentation, and teaching . IEEE Trans Visualization Computer Graphics 1996; 2: 232-241 .

33.

Coffey CE , Wilkinson WE , Weiner RD , Parashos IA , Djang WT , Webb MC et al. Quantitative cerebral anatomy in depression. A controlled magnetic resonance imaging study . Arch Gen Psychiatry 1993; 50: 7-16 .

34.

Bland JM , Altman DG. Measurement error . BMJ 1996; 312: 1654-1654 .

35.

Bland JM , Altman DG. Transformations, means, and confidence intervals . BMJ 1996; 312: 1079-1079 .

36.

Bland JM , Altman DG. The use of transformation when comparing two means . BMJ 1996; 312: 1153-1153 .

37.

Steiger JH. Tests for comparing elements of correlation matrix . Psychol Bull 1980; 87: 245-251 .

38.

Benedict RH , Bakshi R , Simon JH , Priore R , Miller C , Munschauer F. Frontal cortex atrophy predicts cognitive impairment in multiple sclerosis . J Neuropsychiatry Clin Neurosci 2002; 14: 44-51 .

39.

Zivadinov R , Zorzon M , Locatelli L , Stival B , Monti F , Nasuelli D et al. Sexual dysfunction in multiple sclerosis: a MRI, neurophysiological and urodynamic study . J Neurol Sci 2003; 210: 73-76 .

40.

Zorzon M , Zivadinov R , Locatelli L , Stival B , Nasuelli D , Bratina A et al. Correlation of sexual dysfunction and brain magnetic resonance imaging in multiple sclerosis . Mult Scler 2003; 9: 108-110 .

41.

Zorzon M , Zivadinov R , Nasuelli D , Ukmar M , Bratina A , Tommasi MA et al. Depressive symptoms and MRI changes in multiple sclerosis . Eur J Neurol 2002; 9: 491-496 .

42.

Zivadinov R , Bragadin LM , Nasuelli D , De Masi R , Ukmar M , Pozzi-Mucelli RS et al. Magnetic resonance imaging techniques as predictors of cognitive impairment in multiple sclerosis . Nuova Riv Neurol 2001; 11: 35-49 .

43.

Foong J , Rozewicz L , Quaghebeur G , Davie CA , Kartsounis LD , Thompson AJ et al. Executive function in multiple sclerosis. The role of frontal lobe pathology . Brain 1997; 120: 15-26 .

44.

Swirsky-Sacchetti T , Mitchell DR , Seward J , Gonzales C , Lublin F , Knobler R et al. Neuropsychological and structural brain lesions in multiple sclerosis: a regional analysis . Neurology 1992; 42: 1291-1295 .